SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parmax Pharma informs about board meeting

23 May 2023 Evaluate

Parmax Pharma has informed that the Meeting of the Board of Directors of the company will be held on Tuesday, 30th May, 2023 at 12.30 pm to consider, approve the Audited Financial Results of the quarter and financial year ended 31st March, 2023 and to discuss any other matter with the permission of Board. Under its letter dated 31st March, 2023, it had communicated closure of trading window in respect of the Company with immediate effect till 48 hours after public announcement of the Audited Financial Results for the quarter and financial year ended 31st March, 2023. Consequently, the Trading Window will remain closed till 1st June, 2023.

The above information is a part of company’s filings submitted to BSE.


Parmax Pharma Share Price

31.51 -1.48 (-4.49%)
11-May-2026 13:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1873.25
Dr. Reddys Lab 1294.10
Cipla 1321.45
Zydus Lifesciences 948.00
Lupin 2277.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×